Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0028754 (
obesity
)
124,988
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Obesity
is a highly heritable trait and a growing public health problem. African Americans (AAs) are a genetically diverse, yet understudied population with a high prevalence of
obesity
(BMI >30 kg/m(2)). Recent studies based upon single-nucleotide polymorphisms (SNPs) have identified genetic markers associated with
obesity
. However, a large proportion of the heritability of
obesity
remains unexplained. Copy number variation (CNV) has been cited as a possible source of missing heritability in common diseases such as
obesity
. We conducted a CNV genome-wide association study of BMI in two African-American cohorts from Genetic Epidemiology Network of
Arteriopathy
(GENOA) and Hypertension Genetic Epidemiology Network (HyperGEN). We performed independent and identical association analyses in each study, then combined the results in a meta-analysis. We identified three CNVs associated with BMI,
obesity
, and other
obesity
-related traits after adjusting for multiple testing. These CNVs overlap the PARK2, GYPA, and SGCZ genes. Our results suggest that CNV may play a role in the etiology of
obesity
in AAs.
Obesity
(Silver Spring) 2012 Dec
PMID:Copy number variations associated with obesity-related traits in African Americans: a joint analysis between GENOA and HyperGEN. 2283 85
Diabetic foot ulcerations have been extensively reported as vascular complications of diabetes mellitus associated with a high degree of morbidity and mortality. Diabetic foot syndrome (DFS), as defined by the World Health Organization, is an "ulceration of the foot (distally from the ankle and including the ankle) associated with neuropathy and different grades of ischemia and infection". Pathogenic events able to cause diabetic foot ulcers are multifactorial. Among the commonest causes of this pathogenic pathway it's possible to consider peripheral neuropathy, foot deformity, abnormal foot pressures, abnormal joint mobility, trauma, peripheral artery disease. Several studies reported how diabetic patients show a higher mortality rate compared to patients without diabetes and in particular these studies under filled how cardiovascular mortality and morbidity is 2-4 times higher among patients affected by type 2 diabetes mellitus. This higher degree of cardiovascular morbidity has been explained as due to the observed higher prevalence of major cardiovascular risk factor, of asymptomatic findings of cardiovascular diseases, and of prevalence and incidence of cardiovascular and cerebrovascular events in diabetic patients with foot complications. In diabetes a fundamental pathogenic pathway of most of vascular complications has been reported as linked to a complex interplay of inflammatory, metabolic and procoagulant variables. These pathogenetic aspects have a direct interplay with an insulin resistance, subsequent
obesity
, diabetes, hypertension, prothrombotic state and blood lipid disorder. Involvement of inflammatory markers such as IL-6 plasma levels and resistin in diabetic subjects as reported by Tuttolomondo et al confirmed the pathogenetic issue of the a "adipo-vascular" axis that may contribute to cardiovascular risk in patients with type 2 diabetes. This "adipo-vascular axis" in patients with type 2 diabetes has been reported as characterized by lower plasma levels of adiponectin and higher plasma levels of interleukin-6 thus linking foot ulcers pathogenesis to microvascular and inflammatory events. The purpose of this review is to highlight the immune inflammatory features of DFS and its possible role as a marker of cardiovascular risk in diabetes patients and to focus the management of major complications related to diabetes such as infections and peripheral
arteriopathy
.
...
PMID:Diabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetes. 2562 Dec 12
The Tobit model, also known as a censored regression model to account for left- and/or right-censoring in the dependent variable, has been used in many areas of applications, including dental health, medical research and economics. The reported Tobit model coefficient allows estimation and inference of an exposure effect on the latent dependent variable. However, this model does not directly provide overall exposure effects estimation on the original outcome scale. We propose a direct-marginalization approach using a reparameterized link function to model exposure and covariate effects directly on the truncated dependent variable mean. We also discuss an alternative average-predicted-value, post-estimation approach which uses model-predicted values for each person in a designated reference group under different exposure statuses to estimate covariate-adjusted overall exposure effects. Simulation studies were conducted to show the unbiasedness and robustness properties for both approaches under various scenarios. Robustness appears to diminish when covariates with substantial effects are imbalanced between exposure groups; we outline an approach for model choice based on information criterion fit statistics. The methods are applied to the Genetic Epidemiology Network of
Arteriopathy
(GENOA) cohort study to assess associations between
obesity
and cognitive function in the non-Hispanic white participants.
...
PMID:Natural interpretations in Tobit regression models using marginal estimation methods. 2632 51
<< Previous
1
2